Ruxolitinib

Nat Rev Drug Discov. 2012 Feb 1;11(2):103-4. doi: 10.1038/nrd3652.
No abstract available

Publication types

  • News

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Janus Kinase 1 / antagonists & inhibitors
  • Janus Kinase 2 / antagonists & inhibitors
  • Janus Kinases / antagonists & inhibitors*
  • Nitriles
  • Primary Myelofibrosis / drug therapy
  • Pyrazoles / therapeutic use*
  • Pyrimidines

Substances

  • Nitriles
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • Janus Kinase 1
  • Janus Kinase 2
  • Janus Kinases